These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 17412636

  • 1. A genotypic and phenotypic comparison of type III secretion profiles of Pseudomonas aeruginosa cystic fibrosis and bacteremia isolates.
    Wareham DW, Curtis MA.
    Int J Med Microbiol; 2007 Jul; 297(4):227-34. PubMed ID: 17412636
    [Abstract] [Full Text] [Related]

  • 2. Genotypic and phenotypic analysis of type III secretion system in a cohort of Pseudomonas aeruginosa bacteremia isolates: evidence for a possible association between O serotypes and exo genes.
    Berthelot P, Attree I, Plésiat P, Chabert J, de Bentzmann S, Pozzetto B, Grattard F, Groupe d'Etudes des Septicémies à Pseudomonas aeruginosa.
    J Infect Dis; 2003 Aug 15; 188(4):512-8. PubMed ID: 12898437
    [Abstract] [Full Text] [Related]

  • 3. Type 3 secretion system effector genotype and secretion phenotype of longitudinally collected Pseudomonas aeruginosa isolates from young children diagnosed with cystic fibrosis following newborn screening.
    Hu H, Harmer C, Anuj S, Wainwright CE, Manos J, Cheney J, Harbour C, Zablotska I, Turnbull L, Whitchurch CB, Grimwood K, Rose B, FBAL study investigators.
    Clin Microbiol Infect; 2013 Mar 15; 19(3):266-72. PubMed ID: 22329595
    [Abstract] [Full Text] [Related]

  • 4. Comparison of type III secretion system virulence among fluoroquinolone-susceptible and -resistant clinical isolates of Pseudomonas aeruginosa.
    Wong-Beringer A, Wiener-Kronish J, Lynch S, Flanagan J.
    Clin Microbiol Infect; 2008 Apr 15; 14(4):330-6. PubMed ID: 18190571
    [Abstract] [Full Text] [Related]

  • 5. Diverse type III secretion phenotypes among Pseudomonas aeruginosa strains upon infection of murine macrophage-like and endothelial cell lines.
    Stepińska M, Trafny EA.
    Microb Pathog; 2008 May 15; 44(5):448-58. PubMed ID: 18221854
    [Abstract] [Full Text] [Related]

  • 6. Type III secretion system-associated toxins, proteases, serotypes, and antibiotic resistance of Pseudomonas aeruginosa isolates associated with keratitis.
    Zhu H, Conibear TC, Bandara R, Aliwarga Y, Stapleton F, Willcox MD.
    Curr Eye Res; 2006 Apr 15; 31(4):297-306. PubMed ID: 16603462
    [Abstract] [Full Text] [Related]

  • 7. Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections.
    Roy-Burman A, Savel RH, Racine S, Swanson BL, Revadigar NS, Fujimoto J, Sawa T, Frank DW, Wiener-Kronish JP.
    J Infect Dis; 2001 Jun 15; 183(12):1767-74. PubMed ID: 11372029
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infections.
    Peña C, Cabot G, Gómez-Zorrilla S, Zamorano L, Ocampo-Sosa A, Murillas J, Almirante B, Pomar V, Aguilar M, Granados A, Calbo E, Rodríguez-Baño J, Rodríguez-López F, Tubau F, Martínez-Martínez L, Oliver A, Spanish Network for Research in Infectious Diseases (REIPI).
    Clin Infect Dis; 2015 Feb 15; 60(4):539-48. PubMed ID: 25378459
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Widespread pyocyanin over-production among isolates of a cystic fibrosis epidemic strain.
    Fothergill JL, Panagea S, Hart CA, Walshaw MJ, Pitt TL, Winstanley C.
    BMC Microbiol; 2007 May 23; 7():45. PubMed ID: 17521417
    [Abstract] [Full Text] [Related]

  • 15. Expression of ExsA in trans confers type III secretion system-dependent cytotoxicity on noncytotoxic Pseudomonas aeruginosa cystic fibrosis isolates.
    Dacheux D, Attree I, Toussaint B.
    Infect Immun; 2001 Jan 23; 69(1):538-42. PubMed ID: 11119548
    [Abstract] [Full Text] [Related]

  • 16. Genome diversity of Pseudomonas aeruginosa isolates from cystic fibrosis patients and the hospital environment.
    Finnan S, Morrissey JP, O'Gara F, Boyd EF.
    J Clin Microbiol; 2004 Dec 23; 42(12):5783-92. PubMed ID: 15583313
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of type III secretion protein exoenzymes and antimicrobial susceptibility patterns from bloodstream isolates of patients with Pseudomonas aeruginosa bacteremia.
    Garey KW, Vo QP, Larocco MT, Gentry LO, Tam VH.
    J Chemother; 2008 Dec 23; 20(6):714-20. PubMed ID: 19129069
    [Abstract] [Full Text] [Related]

  • 18. Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa.
    Feltman H, Schulert G, Khan S, Jain M, Peterson L, Hauser AR.
    Microbiology (Reading); 2001 Oct 23; 147(Pt 10):2659-2669. PubMed ID: 11577145
    [Abstract] [Full Text] [Related]

  • 19. Phenotypic characterization of clonal and nonclonal Pseudomonas aeruginosa strains isolated from lungs of adults with cystic fibrosis.
    Tingpej P, Smith L, Rose B, Zhu H, Conibear T, Al Nassafi K, Manos J, Elkins M, Bye P, Willcox M, Bell S, Wainwright C, Harbour C.
    J Clin Microbiol; 2007 Jun 23; 45(6):1697-704. PubMed ID: 17392437
    [Abstract] [Full Text] [Related]

  • 20. Pseudomonas aeruginosa infection of airway epithelial cells modulates expression of Kruppel-like factors 2 and 6 via RsmA-mediated regulation of type III exoenzymes S and Y.
    O'Grady EP, Mulcahy H, O'Callaghan J, Adams C, O'Gara F.
    Infect Immun; 2006 Oct 23; 74(10):5893-902. PubMed ID: 16988269
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.